DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 173 filers reported holding DIPLOMAT PHARMACY INC in Q4 2016. The put-call ratio across all filers is 0.38 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,168,000 | -20.9% | 291,870 | -3.1% | 0.00% | -100.0% |
| Q3 2019 | $1,477,000 | -20.9% | 301,355 | -1.8% | 0.00% | 0.0% |
| Q2 2019 | $1,868,000 | +3.1% | 306,792 | -1.6% | 0.00% | 0.0% |
| Q1 2019 | $1,811,000 | -58.3% | 311,665 | -3.5% | 0.00% | -50.0% |
| Q4 2018 | $4,347,000 | -30.9% | 322,902 | -0.3% | 0.00% | 0.0% |
| Q3 2018 | $6,287,000 | -12.4% | 323,961 | +15.3% | 0.00% | -33.3% |
| Q2 2018 | $7,178,000 | +27.2% | 280,855 | +0.3% | 0.00% | 0.0% |
| Q1 2018 | $5,641,000 | -46.3% | 279,930 | -46.5% | 0.00% | -40.0% |
| Q4 2017 | $10,503,000 | +90.0% | 523,300 | +96.0% | 0.01% | +66.7% |
| Q3 2017 | $5,529,000 | +36.8% | 266,929 | -2.2% | 0.00% | +50.0% |
| Q2 2017 | $4,043,000 | +10.8% | 272,979 | +19.3% | 0.00% | 0.0% |
| Q1 2017 | $3,650,000 | +22.2% | 228,844 | -3.5% | 0.00% | 0.0% |
| Q4 2016 | $2,987,000 | -66.0% | 237,062 | -24.5% | 0.00% | -60.0% |
| Q3 2016 | $8,792,000 | +0.5% | 313,896 | +25.7% | 0.01% | 0.0% |
| Q2 2016 | $8,744,000 | +33.2% | 249,788 | +4.3% | 0.01% | +25.0% |
| Q1 2016 | $6,563,000 | +127.7% | 239,552 | +184.5% | 0.00% | +100.0% |
| Q4 2015 | $2,882,000 | +107.0% | 84,205 | +73.8% | 0.00% | +100.0% |
| Q3 2015 | $1,392,000 | -81.8% | 48,457 | -71.7% | 0.00% | -75.0% |
| Q2 2015 | $7,654,000 | -12.3% | 171,072 | -32.2% | 0.00% | -20.0% |
| Q1 2015 | $8,729,000 | -8.6% | 252,430 | -27.7% | 0.01% | -16.7% |
| Q4 2014 | $9,553,000 | – | 349,003 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|